The Select Drug Program Formulary, which is available for commercial 
members, is a list of medications approved by the U.S. Food and Drug 
Administration that were chosen for formulary coverage based on their medical 
effectiveness, safety, and value. The list changes periodically as the Pharmacy 
and Therapeutics Committee reviews the formulary to ensure its continued 
effectiveness. The most recent changes are listed below.
 
Generic additions 
 These generic drugs recently became available in the marketplace. When 
these generic drugs became available, we began covering them at the appropriate 
generic formulary level of cost-sharing:
Generic drug 
	Brand drug 
		Formulary chapter 
			Effective date 
aripiprazole 1 mg/ml 
	Abilify® 1 mg/ml 
		3. Pain, Nervous System, & Psych 
			August 24, 2015 
aripiprazole odt 10 mg and 15 mg 
	Not available 
		3. Pain, Nervous System, & Psych 
			October 12, 2015 
budesonide 1 mg/2 ml 
	Pulmicort® 1 mg/2 ml 
		12. Allergy, Cough & Cold, Lung Meds 
			August 3, 2015 
dihydrocodein-acetaminoph-caff 
	Trezix? 
		3. Pain, Nervous System, & Psych 
			August 17, 2015 
dutasteride 
	Avodart® 
		13. Urinary & Prostate Meds 
			October 19, 2015 
fenofibrate 40 mg 
	Fenoglide® 40 mg 
		4. Heart, Blood Pressure, & Cholesterol 
			September 28, 2015 
fluvastatin er 
	Lescol® XL 
		4. Heart, Blood Pressure, & Cholesterol 
			September 21, 2015 
megestrol acetate 
	Megace® ES 
		2. Cancer & Organ Transplant Drugs 
			August 3, 2015 
memantine hcl 2 mg/ml 
	Namenda® 2 mg/ml 
		3. Pain, Nervous System, & Psych 
			October 19, 2015 
naproxen sodium cr 375 mg 
	Naprelan® 375 mg 
		3. Pain, Nervous System, & Psych 
			August 31, 2015 
paliperidone er 
	Invega® 
		3. Pain, Nervous System, & Psych 
			September 28, 2015 
phenoxybenzamine hcl 
	Dibenzyline® 
		4. Heart, Blood Pressure, & Cholesterol 
			August 17, 2015 
pimozide 
	Orap® 
		3. Pain, Nervous System, & Psych 
			October 5, 2015 
pramipexole di-hcl 4.5 mg 
	Mirapex ER® 4.5 mg 
		3. Pain, Nervous System, & Psych 
			August 17, 2015 
rivastigmine 9.5 mg/24 hr, 13.3 mg/24 hr, and 4.6 mg/24 hr 
	Exelon® 9.5 mg/24 hr, 13.3 mg/24 hr, and 4.6 mg/24 hr 
		3. Pain, Nervous System, & Psych 
			September 7, 2015 
tetrabenazine* 
	Xenazine® 
		3. Pain, Nervous System, & Psych 
			August 31, 2015 
tretinoin 
	Atralin® 
		5. Skin Medications 
			September 7, 2015 
			
  
			*Generic requires prior 
authorization.
   
			Brand deletions 
			
Effective April 1, 2016, these brand drugs will be covered 
at the appropriate non-formulary level of cost-sharing: 
			
Brand drug 
	Generic drug 
		Formulary chapter 
Abilify® 1 mg/ml 
	aripiprazole 1 mg/ml 
		3. Pain, Nervous System, & Psych 
Mirapex ER® 4.5 mg 
	pramipexole di-hcl 4.5 mg 
		3. Pain, Nervous System, & Psych 
Namenda® 2 mg/ml 
	memantine hcl 2 mg/ml 
		3. Pain, Nervous System, & Psych 
		
  
		The generic drugs for the above brand drugs are on our formulary and 
available at the generic formulary level of cost-sharing.